Rubicon Research IPO Subscribed 11 Times on Day 3 of Bidding
The initial public offering of Rubicon Research, a pharmaceutical formulation company, has witnessed an 11 times subscription on the third day of bidding, October 13. Investor interest continues to remain strong, reflecting confidence in the company’s growth and R&D focus.By mid-day, the IPO ...
Easy & quick